Cross-sectional and longitudinal assessment of uremia-related substances' concentration associated with kidney function in chronic kidney disease patients
Not Applicable
- Conditions
- Chronic kidney disease, stage 3-5
- Registration Number
- JPRN-UMIN000023772
- Lead Sponsor
- Osaka General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignant tumor (including hematologic malignancy), hematologic disease, hepatic cirrhosis, severe infection, severe cognitive impairment, or apparent hemorrhagic lesion. Patients who are judged to be inappropriate for the study participants by principal investigator or subinvestigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sialidase activity
- Secondary Outcome Measures
Name Time Method Erythroferrone, Myostatin, Apelin